NMS Group S.p.A. is the largest company in Italy committed in innovation and oncology R&D. With 420 total employees, NMS Group employs over 200 qualified researchers involved in research and development, from 'target validation' to phase II clinical trials. NMS Group S.p.A. is the only company in Italy able to manage the entire integrated chain of the research and development path: from pre-clinical phase of research, to First-Time-In-Man of clinical phase, up to production and packaging of the finished drug. The Group also provides services of Research and Production addressed to local and international markets through three different companies: Accelera, one of the few companies engaged in preclinical research in Italy; Clioss engaged in clinical development starting from First-Time-In-Man and Nerpharma, dealing with activities from formulation to production of the active principle.
View Top Employees from NMS GroupWebsite | http://www.nmsgroup.it |
Revenue | $5 million |
Employees | 80 (49 on RocketReach) |
Address | 10 Via Pasteur, Nerviano, Mi 20014, IT |
Phone | +39 331 581 111 |
Industry | Research Services, Business Services General, Discovery by Nerviano Medical Sciences, Business Services, Preclinical research by Accelera, Clinical development starting from First-Time-In-Man by Clioss, From formulation to production of the active principle by Nerpha |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular NMS Group employee's phone or email?
The NMS Group annual revenue was $5 million in 2024.
Hugues Dolgos is the CEO of NMS Group.
49 people are employed at NMS Group.
NMS Group is based in Nerviano, Mi.
The NAICS codes for NMS Group are [32541, 32, 3254, 325].
The SIC codes for NMS Group are [283, 28].